美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06667 美因基因

休市中 02-27 15:59:27

7.290

+0.090

+1.25%

最高7.530	最低6.500	成交量2.06万
今开7.510	昨收7.200	日振幅14.31%
总市值16.33亿	流通市值16.33亿	总股本2.24亿
成交额14.91万	换手率0.01%	流通股本2.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":7.29,"timestamp":1772179167054,"preClose":7.2,"halted":0,"volume":20600,"delay":0,"changeRate":0.01249999999999998,"floatShares":224000000,"shares":224000000,"eps":0.24748664644125612,"marketStatus":"休市中","change":0.09,"latestTime":"02-27 15:59:27","open":7.51,"high":7.53,"low":6.5,"amount":149094,"amplitude":0.143056,"askPrice":7.3,"askSize":4000,"bidPrice":7.24,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.18854486606793613,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":7,"adr":0,"listingDate":1655827200000,"exchange":"SEHK","adjPreClose":7.2,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":0.2713382508617856,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667/wiki","defaultTab":"wiki","newsList":[{"id":"2614003168","title":"港股通天酒业、美因基因今日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2614003168","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614003168?lang=zh_cn&edition=full","pubTime":"2026-02-27 08:19","pubTimestamp":1772151540,"startTime":"0","endTime":"0","summary":"港股通天酒业、美因基因今日复牌","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602273656048914.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602273656048914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00389","VT","BK1219","06667","BK4585","BK1192","VXUS","BK4588"],"gpt_icon":0},{"id":"2614041877","title":"美因基因(06667)达成复牌指引 2月27日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2614041877","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614041877?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:42","pubTimestamp":1772109739,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，公司已达成所有复牌指引。公司已申请于2026年2月27日上午9时正起恢复公司股份于联交所买卖。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因(06667)达成复牌指引 2月27日复牌","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"1178574602","title":"美因基因2025年上半年营收0.81亿元，经调整净利润0.27亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178574602","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178574602?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:52","pubTimestamp":1770641532,"startTime":"0","endTime":"0","summary":"美因基因公布2025年上半年财务数据，营收人民币0.81亿元，同比下降24.2%。经调整净利润人民币0.27亿元，同比下降26.3%。管理层将营收下滑主要归因为销售策略调整，短期内收入减少叠加房租、人工及折旧等相对固定成本所致。期内经营活动现金流由上年同期的人民币1497.3万元转为本期的-129.3万元。消费级基因检测的服务及配套实现收入人民币0.76亿元，同比下降27.3%。癌症筛查的服务及配套录得人民币0.05亿元收入，同比大幅增长85.7%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"gpt_icon":0},{"id":"2608983653","title":"美因基因(06667)发布2025年中期业绩，净利润2730万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608983653","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608983653?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:27","pubTimestamp":1770215229,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布截至2025年6月30日止6个月的中期业绩，报告期内，本公司实现营业收入人民币8130万元，营业收入同比下降24.2%;实现净利润人民币2730万元，净利润同比下降26.3%。本期营业收入及净利润同比下滑，主要由于本公司调整销售策略，营业收入阶段性下降，同时人工、房租、折旧等成本相对固定，净利润减少。截至2025年6月30日，我们与中国超过340个城市的医疗保健机构合作，我们的销售及营销网络使我们能够向大部分中国人口提供基因检测服务。此外，我们与多家电子商务及线上医疗保健平台合作，以扩大及完善销售及营销网络。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667"],"gpt_icon":0},{"id":"1157713145","title":"美因基因（06667）1月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1157713145","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157713145?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:48","pubTimestamp":1770043693,"startTime":"0","endTime":"0","summary":"美因基因有限公司（股票代码：06667）于2026年2月2日发布截至2026年1月31日的股份变动月报表。报告显示，公司注册股本维持在500,000,000股，面值每股0.0001美元，法定股本总额约50,000美元，较上月无任何变化。\n公司已发行普通股数量仍为224,300,200股，期间无新增发行、回购或注销活动，亦无库藏股持有，股本结构保持稳定，符合香港联交所的公眾持股量要求。\n报告显示无任何股份期权、可换股票据或其他股权激励计划的变动记录。公司确认遵守香港联交所《上市规则》及相关法律规定。该公告由董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"gpt_icon":0},{"id":"1181928060","title":"消费者基因检测业务驱动收入稳增，2024年度净利润同比提升50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181928060","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181928060?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:58","pubTimestamp":1769777923,"startTime":"0","endTime":"0","summary":"截至2024年12月31日止年度，公司实现收入人民币164,226千元，较上年同期的人民币151,300千元增长8.5%。其中，消费者级基因检测的服务及配套收入为人民币159,594千元，同比上升47.3%；癌症筛查的服务及配套收入则降至人民币4,632千元，同比减少89.2%。毛利率、净利率及流动比率均较去年有所提升，整体反映消费者级基因检测业务带动收入增长及盈利能力增强，资产负债结构保持较高流动性水平。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"gpt_icon":0},{"id":"2607043866","title":"美因基因(06667)公布2024年业绩 实现净利润4500万元 同比增长50.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607043866","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607043866?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:55","pubTimestamp":1769777741,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)公布2024年业绩，实现营业收入约1.64亿元，同比增长8.5%。实现净利润4500万元，同比增长50.0%。每股盈利0.22元。公告称，主要由于公司坚持产品设计创新，持续丰富产品矩阵、优化产品结构，同时采取积极的市场拓展策略，持续探索更多的销售场景及渠道，不断挖掘潜在市场需求及销售机遇，搭建多元化的销售体系，进一步提升客户服务体验，推动收入和净利润实现稳步增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因(06667)公布2024年业绩 实现净利润4500万元 同比增长50.0%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667"],"gpt_icon":0},{"id":"2604113221","title":"美因基因(06667.HK)拟于1月30日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113221","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604113221?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:47","pubTimestamp":1768913221,"startTime":"0","endTime":"0","summary":"格隆汇1月20日丨美因基因(06667.HK)公告，谨定于2026年1月30日举行公司董事会会议，以考虑及通过集团截至2024年12月31日止年度的全年业绩公告及其发布，及建议末期股息(如有)，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260120/31957558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"1190472145","title":"美因基因（06667）2025年12月无新增发行或股份变动，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1190472145","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190472145?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:05","pubTimestamp":1767582348,"startTime":"0","endTime":"0","summary":"美因基因有限公司（「公司」或「美因基因」，股份代号：06667）于2026年1月5日发布截至2025年12月31日的股份变动月报表。\n公告显示，公司本月底法定/注册股本维持在500,000,000股，面值每股USD 0.0001，对应注册股本总额USD 50,000，与上月相同。\n截至报告期末，公司已发行普通股数量为224,300,200股，较上月底无任何增发、购回、注销或库藏变化。公司月内亦无股份期权、可换股票据等其他权利或激励计划的变动记录。\n公司声明其股本管理符合香港联交所《上市规则》及相关法律法规。本次月报由董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"gpt_icon":0},{"id":"1183723407","title":"美因基因（06667）2025年11月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1183723407","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183723407?lang=zh_cn&edition=full","pubTime":"2025-12-01 19:22","pubTimestamp":1764588178,"startTime":"0","endTime":"0","summary":"美因基因有限公司（06667）于2025年12月1日发布2025年11月股份变动月报表。公告显示，截至2025年11月30日，公司注册股本维持在500,000,000股，面值0.0001美元，注册股本总额为50,000美元，与上月保持一致。\n公司于本月末已发行股份（不含库存股）总数为224,300,200股，同样与上月持平。当月无新增发行、购回或注销股份，亦无相关期权、权证或可换股票据的发行或变动。\n公告强调，公司已经遵守香港联合交易所有限公司《上市规则》及相关法律法规，并由董事姜晶签署确认。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"gpt_icon":0},{"id":"2582162380","title":"美因基因发布独立法证调查结果：收入确认不当，公司继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2582162380","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582162380?lang=zh_cn&edition=full","pubTime":"2025-11-11 09:38","pubTimestamp":1762825101,"startTime":"0","endTime":"0","summary":"11月11日，美因基因（06667）发布公告，独立法证调查的主要结果已出炉，公司将继续暂停买卖。根据公告，公司于2025年5月23日接获联交所的复牌指引，需就审计问题进行独立法证调查，评估对公司业务运营及财务状况的影响。调查内容主要涉及基因检测试剂盒的预收款确认收入和推广费用的合理性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511113560647179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"2514809189","title":"美因基因(06667)2月27日斥资444.3万港元回购57.04万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514809189","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514809189?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:33","pubTimestamp":1740659582,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2025年2月27日斥资444.3万港元回购57.04万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"2514817408","title":"美因基因盘中异动 早盘股价大跌5.93%报7.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514817408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514817408?lang=zh_cn&edition=full","pubTime":"2025-02-27 10:59","pubTimestamp":1740625159,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘10时59分，美因基因股票出现波动，股价大幅跳水5.93%。截至发稿，该股报7.450港元/股，成交量7.44万股，换手率0.03%，振幅5.93%。资金方面，该股资金流入7.2078万港元，流出4.753万港元。美因基因股票所在的生物技术行业中，整体跌幅为1.20%。其相关个股中，北海康成-B、科笛-B、康宁杰瑞制药-B涨幅较大，振幅较大的相关个股有北海康成-B、创胜集团-B、永泰生物-B，振幅分别为58.68%、34.62%、31.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022710591998944d45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022710591998944d45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1219","06667"],"gpt_icon":0},{"id":"2514870958","title":"美因基因回购21万股股份 总金额168万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514870958","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514870958?lang=zh_cn&edition=full","pubTime":"2025-02-26 18:11","pubTimestamp":1740564688,"startTime":"0","endTime":"0","summary":"2月26日，美因基因（06667）发布公告，2025年2月26日，公司回购股份21万股，回购金额为168万港元。根据回购授权的决议，公司可回购的股份总数为2363万股，已回购股份1055万股，占回购授权决议通过时已发行股份的4.4654%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502263330434541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1219","06667"],"gpt_icon":0},{"id":"2514073680","title":"美因基因盘中异动 大幅跳水5.97%报7.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514073680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514073680?lang=zh_cn&edition=full","pubTime":"2025-02-26 10:40","pubTimestamp":1740537636,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘10时40分，美因基因股票出现异动，股价快速下挫5.97%。截至发稿，该股报7.400港元/股，成交量25.36万股，换手率0.11%，振幅9.40%。资金方面，该股资金流入21.739万港元，流出16.6242万港元。美因基因股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，科济药业-B、同源康医药-B、创胜集团-B涨幅较大，振幅较大的相关个股有科济药业-B、同源康医药-B、腾盛博药-B，振幅分别为26.16%、21.59%、15.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226104036a2543423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226104036a2543423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"2514089476","title":"美因基因2月24日斥资220.5万港元回购28.34万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514089476","media":"新浪港股","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514089476?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:24","pubTimestamp":1740446640,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　美因基因（06667）发布公告，于2025年2月24日斥资220.5万港元回购28.34万股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-25/doc-inemrzsm4737315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"2514276089","title":"美因基因回购28万股 总金额220万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514276089","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514276089?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:08","pubTimestamp":1740445691,"startTime":"0","endTime":"0","summary":"2月25日，美因基因（06667）发布公告，2025年2月24日，公司回购股份28万股，回购金额为220万港元。根据回购授权的决议，公司可回购的股份总数为2363万股，已回购股份1018万股，占回购授权决议通过时已发行股份的4.3066%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502253328493214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1219","06667"],"gpt_icon":0},{"id":"2513726510","title":"美因基因(06667)2月24日斥资220.5万港元回购28.34万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726510","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513726510?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:05","pubTimestamp":1740402347,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2025年2月24日斥资220.5万港元回购28.34万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"2513927477","title":"美因基因盘中异动 下午盘快速下挫5.61%报7.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513927477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513927477?lang=zh_cn&edition=full","pubTime":"2025-02-24 13:16","pubTimestamp":1740374216,"startTime":"0","endTime":"0","summary":"2025年02月24日下午盘13时16分，美因基因股票出现波动，股价大幅跳水5.61%。截至发稿，该股报7.400港元/股，成交量28.14万股，换手率0.12%，振幅8.67%。资金方面，该股资金流入7.2472万港元，流出28.5748万港元。美因基因股票所在的生物技术行业中，整体跌幅为2.65%。其相关个股中，腾盛博药-B、创胜集团-B、永泰生物-B涨幅较大，振幅较大的相关个股有腾盛博药-B、永泰生物-B、创胜集团-B，振幅分别为29.75%、20.61%、16.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224131656989060d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224131656989060d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06667","BK1219"],"gpt_icon":0},{"id":"2513890267","title":"【美因基因(06667.HK)2月21日斥资75.2万港元回购9.6万股】美因基因(06667.HK)发布公告，该公司于2025年2月21日斥资75.2万港元回购9.6万股股份，每股回购价格为7.52-7.86港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513890267","media":"金融界","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513890267?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:53","pubTimestamp":1740142390,"startTime":"0","endTime":"0","summary":"美因基因(06667.HK)发布公告，该公司于2025年2月21日斥资75.2万港元回购9.6万股股份，每股回购价格为7.52-7.86港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21205348319043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1219","06667"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0125},{"period":"1month","weight":0.0125},{"period":"3month","weight":0.0125},{"period":"6month","weight":0.0125},{"period":"1year","weight":-0.0215},{"period":"ytd","weight":0.0125}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要从事提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过两个分部运营其业务。消费级基因检测分部从事提供脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、成人全外显子组测序套餐等。癌症筛查服务分部从事提供阿尔茨海默症筛查试剂盒、结直肠癌筛查试剂盒、胃癌筛查试剂盒、肺结节辅助诊断试剂盒及宫颈癌筛查试剂盒。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}